Quantcast

Posts related to ‘THRX’

Theravance Jumps on Glaxo Investment (THRX, GSK)

Posted: April 2, 2012 at 12:23 pm

Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average ...
Read Full Story »

24/7 Wall St. Closing Bell (COST, XOM, AKAM, P, SCCO, MRK, AYI, CBST, AA, INHX, PSOF, IDIX, NFLX, THRX, LTRX)

Posted: January 9, 2012 at 4:07 pm

US markets opened up slightly this morning and have maintained a slight positive tone for most of the day. Today marks the unofficial beginning of another earnings season, with Alcoa ...
Read Full Story »

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

Posted: December 28, 2011 at 7:01 am

The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each ...
Read Full Story »

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

Posted: December 29, 2010 at 1:47 pm

2010 is ending and 2011 is about to begin.  It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there ...
Read Full Story »

Best BioHealth Stocks of 2010, Outlook for 2011 (JAZZ, DNDN, HGSI, ARIA, AMRN, NBIX, THRX)

Posted: November 30, 2010 at 11:32 am

2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the ten-baggers that were seen in 2009.  In 2009, companies like ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (BKD, EOG, ITRI, K, PTEN, PEET, PGR, THRX, VALE, VRSN)

Posted: March 29, 2010 at 7:38 am

These are this Monday's top ten analyst upgrades and downgrades seen from Wall Street research calls: Brookdale Senior Living Inc. (NYSE: BKD) Removed from Goldman Sachs Conviction Buy List. EOG ...
Read Full Story »

BioHealth Business Daily (APPA, GENZ, GENT, MRK, OSIP, OXGN, SOMX, THRX, CLDX)

Posted: March 19, 2010 at 11:39 am

We are seeing many key movers in the BioHealth space today as drug and biotech stocks often exhibit the most volatility of any sector.  Today's BioHealth Business Daily includes the ...
Read Full Story »
biotech

The Next Blockbuster Drugs: A $170 Billion Opportunity

Posted: July 22, 2009 at 4:01 am

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential ...
Read Full Story »
Money_stack_pic

Top Pre-Market Analyst Upgrades (AEZS, AKAM, CNQR, HK, SJT, SGMO, THRX)

Posted: February 5, 2009 at 7:51 am

These are some of the top pre-market analyst upgrades and positive calls from Wall Street this Thursday morning:AEterna Zentaris (AEZS) Raised to Outperform at RBC.Akamai Tech (AKAM) Raised to Buy ...
Read Full Story »

Biotech Busine$$ Daily (AMLN, BIIB, CEPH, CYTK, ONXX, REGN, THRX, CBM)

Posted: March 24, 2008 at 2:00 pm

Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up ...
Read Full Story »

52-Week Low Club (December 28, 2007)

Posted: December 28, 2007 at 3:01 pm

Some of these stocks hit 52-week lows and recovered off of lows so they won't have a low close.  But these did all touch or breach the 52-week lows.  At ...
Read Full Story »

Pre-Market Stock News (July 10, 2007)

Posted: July 10, 2007 at 7:08 am

(AA) Alcoa $0.81 EPS vs $0.81e; will likely have to sweeten Alcan bid before getting any approval from Alcan.(BOT) CBOT holders approve the CME merger offer.(CACS) Carrier Access lowered guidance.(CAKE) ...
Read Full Story »